Session Details

F010 Agentic AI for Dermatologists: Practical Applications, Safety, and Workflow Integration

Fri, Mar 19, 1:00 PM - 3:00 PM
2 CME Available Forum NEW

DESCRIPTION

Agentic AI represents the next evolution of artificial intelligence, enabling systems to autonomously plan, reason, retrieve information, and execute multistep tasks with limited human input. This session will introduce the core concepts of agentic AI and explore emerging applications in dermatology, including clinical documentation, patient communication, workflow automation, decision support, teledermatology, and research augmentation. Faculty will discuss practical opportunities, implementation challenges, and governance considerations related to safety, transparency, bias, liability, and physician oversight. This session is designed for dermatologists, trainees, healthcare leaders, educators, researchers, and industry stakeholders interested in the future of AI-enabled dermatologic care.

LEARNING OBJECTIVES

1.

Define agentic AI and distinguish it from traditional machine learning and generative AI applications in dermatology.

2.

Evaluate emerging clinical, operational, educational, and research applications of agentic AI across dermatology workflows, including documentation, triage, decision support, and patient engagement.

3.

Identify key challenges related to safety, governance, bias, accountability, privacy, and human oversight when implementing agentic AI systems in dermatologic practice.

SCHEDULE

1:00 PM

Agentic AI for Dermatologists: Practical Applications, Safety, and Workflow Integration

DIRECTOR

Ivy Lee, MD, FAAD

Ivy Lee, MD, FAAD

SPEAKER

Daniel Isaac Schlessinger, MD, FAAD

Daniel Isaac Schlessinger, MD, FAAD

University of Nebraska Medical Center

DISCLOSURES

Ivy Lee, MD, FAAD

Direct Dermatology – Stockholder(Stock Options); L'Oreal – Speaker/Faculty Education(Honoraria);

Daniel Isaac Schlessinger, MD, FAAD

Abbvie – Consultant (1099 relationship)(Fees); AbbVie – Investigator(Fees); Almirall – Investigator(Fees); Alumis – Investigator(Fees); Apollo Therapeutics Ltd – Investigator(Fees); Appiell Inc. – Consultant(Stock); Caliway Biopharmaceuticals Co., Ltd – Investigator(Fees); Celldex – Investigator(Fees); Croma-Pharma GmbH Austria – Advisory Board(Fees); Elf Cosmetics – Stockholder Public Company(Stock); FixMySkin – Founder(Patent royalties or other compensation for Intellectual Property Rights); Incyte Corporation – Investigator(Fees); Ipsen – Investigator(Fees); K-Health – Stockholder(No Compensation Received); LovelySkin – Employee (w-2 relationship)(Salary); LuminDx – Consultant(No Compensation Received); MoonLake Immunotherapeutics – Investigator(Fees); Nielsen BioSciences – Advisory Board(Stock), Investigator(Fees); Novartis – Investigator(Fees); Obagi Medical – Advisory Board(Fees); Oruka Therapeutics – Investigator(Fees); Pfizer Inc. – Investigator(Fees); ProTransit Nanotherapy – Advisory Board(Stock), Investigator(Fees); Sanofi – Investigator(Fees); Sun Pharmaceutical Industries Ltd. – Investigator(Fees); Takeda Pharmaceuticals USA Inc – Investigator(Fees); UCB – Investigator(Fees); Vanda Pharmaceuticals Inc. – Investigator(Fees); VeraDermics Inc. – Advisory Board(Honoraria); Verrica Pharmaceuticals Inc. – Investigator(Fees); Wontech – Speaker(Fees);